S W Hildreth
Overview
Explore the profile of S W Hildreth including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
544
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tondella M, Carlone G, Messonnier N, Quinn C, Meade B, Burns D, et al.
Vaccine
. 2008 Dec;
27(6):803-14.
PMID: 19071179
An international meeting on Bordetella pertussis assay standardization and harmonization was held at the Centers for Disease Control and Prevention (CDC), Atlanta, GA, 19-20 July 2007. The goal of the...
2.
Sikkema D, Friedman K, Corsaro B, Kimura A, Hildreth S, Madore D, et al.
Clin Diagn Lab Immunol
. 2000 Sep;
7(5):764-8.
PMID: 10973451
A new meningococcal group C-CRM(197) conjugate vaccine (MnCC; Meningitec) has been evaluated in multiple clinical trials in the United States and most recently has been approved for routine administration in...
3.
Piedra P, Glezen W, KASEL J, Welliver R, Jewel A, Rayford Y, et al.
Vaccine
. 1995 Aug;
13(12):1095-101.
PMID: 7491817
PFP-1 vaccine was evaluated in a randomized, controlled study in 47 RSV seropositive children. Trivalent inactivated influenza virus (TIV) vaccine was the control. Vaccine reactions were monitored, and bloods were...
4.
Paradiso P, Hildreth S, Hogerman D, Speelman D, Lewin E, Oren J, et al.
Pediatr Infect Dis J
. 1994 Sep;
13(9):792-8.
PMID: 7808848
A subunit vaccine for respiratory syncytial virus (RSV) consisting of purified fusion glycoprotein (designated PFP-1) was tested in children 24 to 48 months old. Two doses of 20 micrograms (n...
5.
Tristram D, Welliver R, Hogerman D, Hildreth S, Paradiso P
Vaccine
. 1994 May;
12(6):551-6.
PMID: 8036830
In a previous study, children 18 to 36 months of age and seropositive for respiratory syncytial virus (RSV) were vaccinated with an RSV subunit vaccine (PFP-1) consisting of the viral...
6.
Hancock G, Hahn D, Speelman D, Hildreth S, Pillai S, McQueen K
Vaccine
. 1994 Jan;
12(3):267-74.
PMID: 8165859
We have investigated the efficacy of vaccination with the purified fusion (F) protein of respiratory syncytial virus (RSV) on aluminium hydroxide adjuvant in Balb/c mice. The purpose of the study...
7.
Piedra P, Wyde P, Castleman W, Ambrose M, JEWELL A, Speelman D, et al.
Vaccine
. 1993 Nov;
11(14):1415-23.
PMID: 7508665
The specificity of viral antigens in the formalin-inactivated, alum-precipitated respiratory syncytial virus (FI-RSV) vaccine in augmenting the pulmonary inflammatory response was evaluated. Cotton rats were immunized with a FI-RSV vaccine...
8.
Expression of the G glycoprotein gene of human respiratory syncytial virus in Salmonella typhimurium
Fleischer E, Doyle S, Arumugham R, Collins P, Hildreth S, Paradiso P
J Gen Virol
. 1993 Mar;
74 ( Pt 3):453-8.
PMID: 8445368
The attachment protein, G, of human respiratory syncytial virus (RSV) is an M(r) 84K to 90K species which has a high content of N-linked and O-linked carbohydrates. The unglycosylated form...
9.
Tristram D, Welliver R, Mohar C, Hogerman D, Hildreth S, Paradiso P
J Infect Dis
. 1993 Jan;
167(1):191-5.
PMID: 8418166
Twenty-six children (aged 18-36 months) previously hospitalized for respiratory syncytial virus (RSV) infection were randomized to receive 50 micrograms of an RSV subunit vaccine composed primarily of F glycoprotein or...
10.
Hildreth S, Baggs R, Brownstein D, Castleman W, Paradiso P
Vaccine
. 1993 Jan;
11(6):689-90.
PMID: 8322496
No abstract available.